À compter du 1er décembre 2023, l’accès à POEMs et à Essential Evidence Plus ne fera plus partie des avantages offerts aux membres de l’AMC.
Question clinique
For patients with gastroesophageal reflux disease that doesn't respond to twice-daily omeprazole, is surgery superior to medical therapy?
L’Essentiel
In carefully selected patients whose acid reflux symptoms correspond to periods of high acidity based on pH monitoring, surgery was more effective than optimal medical therapy. This study is limited by its small size. 1b-
Référence
Plan de l'etude: Randomized controlled trial (nonblinded)
Financement: Government
Cadre: Outpatient (any)
Sommaire
These researchers identified patients referred for gastroesophageal reflux disease (GERD) unresponsive to whatever proton pump inhibitor (PPI) they were taking. Patients with severe reflux esophagitis, non-GERD endoscopic abnormalities, achalasia, or absent contractility were excluded. All patients were taken off their current PPI and given omeprazole 20 mg twice daily. Those patients who had an improvement of less than 50% in their GERD-HRQL score (ie, treatment failure) completed a baseline general quality of life scale, a depression scale, and an anxiety scale, and underwent pH monitoring while taking the omeprazole. They were enrolled in the study only if they had an association between their acid reflux symptoms and a pH of less than 4.0, and were approved by the study surgeon. Of 366 patients who entered the gauntlet, only 78 met these criteria and were randomized into 1 of 3 groups: (1) surgical treatment with laparoscopic Nissen fundoplication; (2) omeprazole 20 mg twice daily plus baclofen, followed by desipramine if baclofen failed; and (3) omeprazole 20 mg twice daily plus a baclofen placebo, followed by a desipramine placebo if the baclofen placebo failed. The primary outcome was treatment success at one year defined as at least a 50% improvement in the GERD-HRQL score. Groups were fairly well-balanced and analysis was by intention to treat. At one year, treatment success occurred in 67% in the surgery group, 28% in the active medical therapy group, and 12% in the group who received omeprazole but placebo for baclofen and desipramine. The difference between the surgery and medical groups was statistically significant, with a number needed to treat of 3 for the comparison between surgery and active medical therapy. Major adverse events were similar between groups, although one surgical patient required repeat surgery that was complicated by postoperative pneumonia. This was a Veterans Affairs study, so the population may not be as representative as it could be.
Reviewer
Mark H. Ebell, MD, MS
Professor
University of Georgia
Athens, GA